BRD4 degradation by PROTACs represents a more effective therapeutic strategy than BRD4 inhibitors in ovarian cancer

被引：0
|
作者：
Raina, Kanak
Lu, Jing
Qian, Yimin
Altieri, Martha
Dong, Hanging
Wang, Jing
Chen, Xin
Crew, Andrew
Coleman, Kevin
Crews, Craig
Winkler, James
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-4710
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4710
引用
收藏
页数：3
相关论文
共 50 条
  • [1] BRD4 Degradation By Protacs Represents a More Effective Therapeutic Strategy Than BRD4 Inhibitors in DLBCL
    Lu, Jing
    Qian, Yimin
    Raina, Kanak
    Altieri, Martha
    Dong, Hanqing
    Wang, Jing
    Chen, Xin
    Crew, Andrew
    Coleman, Kevin
    Crews, Craig
    Winkler, James
    BLOOD, 2015, 126 (23)
  • [2] Methylation of BRD4 by PRMT1 regulates BRD4 phosphorylation and promotes ovarian cancer invasion
    Liu, Yi
    Liu, Hejing
    Ye, Miaomiao
    Jiang, Mengying
    Chen, Xin
    Song, Gendi
    Ji, Huihui
    Wang, Zhi-wei
    Zhu, Xueqiong
    CELL DEATH & DISEASE, 2023, 14 (09)
  • [3] Methylation of BRD4 by PRMT1 regulates BRD4 phosphorylation and promotes ovarian cancer invasion
    Yi Liu
    Hejing Liu
    Miaomiao Ye
    Mengying Jiang
    Xin Chen
    Gendi Song
    Huihui Ji
    Zhi-wei Wang
    Xueqiong Zhu
    Cell Death & Disease, 14
  • [4] Targeting Brd4 for cancer therapy: inhibitors and degraders
    Duan, Yingchao
    Guan, Yuanyuan
    Qin, Wenping
    Zhai, Xiaoyu
    Yu, Bin
    Liu, Hongmin
    MEDCHEMCOMM, 2018, 9 (11) : 1779 - 1802
  • [5] Dual HDAC/BRD4 inhibitors against cancer
    Omidkhah, Negar
    Hadizadeh, Farzin
    Ghodsi, Razieh
    MEDICINAL CHEMISTRY RESEARCH, 2021, 30 (10) : 1822 - 1836
  • [6] Dual HDAC/BRD4 inhibitors against cancer
    Negar Omidkhah
    Farzin Hadizadeh
    Razieh Ghodsi
    Medicinal Chemistry Research, 2021, 30 : 1822 - 1836
  • [7] BRD4 inhibitors block telomere elongation
    Wang, Steven
    Pike, Alexandra M.
    Lee, Stella S.
    Strong, Margaret A.
    Connelly, Carla J.
    Greider, Carol W.
    NUCLEIC ACIDS RESEARCH, 2017, 45 (14) : 8403 - 8410
  • [8] Review on: BRD4 inhibitors for anticancer research
    Singh, Vindhya Vikram
    Alauddin, Shafqat
    HUMAN GENE, 2023, 37
  • [9] Adjusted degradation of BRD4 S and BRD4 L based on fine structural modifications of the pyrrolopyridone scaffold
    Chen, Jingjing
    He, Huixin
    Wei, Aihuan
    Li, Yalei
    Cheng, Gang
    Qin, Hui
    Zhong, Hanyue
    Liu, Hongchun
    Geng, Meiyu
    Shen, Aijun
    Hu, Youhong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 236
  • [10] BRD4 is a new therapeutic target in melanoma
    Fontanals-Cirera, Barbara
    Segura, Miguel F.
    Gaziel-Sovran, Avital
    Guijarro, Maria V.
    Hanniford, Doug
    Gonzalez-Gomez, Pilar
    Zhang, Weijia
    Zhang, Guantao
    Darvishian, Farbod
    Ohlmeyer, Michael
    Osman, Iman
    Zhou, Ming-Ming
    Hernando, Eva
    CANCER RESEARCH, 2013, 73
12345